These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2604772)

  • 1. Serum CA 125 in acute pelvic inflammatory disease.
    Paavonen J; Miettinen A; Heinonen PK; Aaran RK; Teisala K; Aine R; Punnonen R; Laine S; Kallioniemi OP; Lehtinen M
    Br J Obstet Gynaecol; 1989 May; 96(5):574-9. PubMed ID: 2604772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentration of protein CA-125 in women with pelvic inflammatory disease.
    Brumsted JR; Mead PB; Gibson M
    Sex Transm Dis; 1988; 15(3):144-7. PubMed ID: 3227470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CA 125 levels in patients with a provisional diagnosis of pelvic inflammatory disease. Clinical and theoretical implications.
    Duk JM; Kauer FM; Fleuren GJ; de Bruijn HW
    Acta Obstet Gynecol Scand; 1989; 68(7):637-41. PubMed ID: 2631530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum C-reactive protein determination in acute pelvic inflammatory disease.
    Lehtinen M; Laine S; Heinonen PK; Teisala K; Miettinen A; Aine R; Punnonen R; Grönroos P; Paavonen J
    Am J Obstet Gynecol; 1986 Jan; 154(1):158-9. PubMed ID: 2936244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CA-125 in the diagnosis of acute pelvic inflammatory disease.
    Mozas J; Castilla JA; Jimena P; Gil T; Acebal M; Herruzo AJ
    Int J Gynaecol Obstet; 1994 Jan; 44(1):53-7. PubMed ID: 7907059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiological and histopathological findings in acute pelvic inflammatory disease.
    Paavonen J; Teisala K; Heinonen PK; Aine R; Laine S; Lehtinen M; Miettinen A; Punnonen R; Grönroos P
    Br J Obstet Gynaecol; 1987 May; 94(5):454-60. PubMed ID: 3580330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contraception and pelvic infection in women].
    Keith L; Berger GS; Brown ER
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):49-58. PubMed ID: 12341241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of detecting CA-125 antigen in patients with gynecologic diseases].
    Adamian LV; Alekseeva ML; Andreeva EN; Novikov EA; Fanchenko ND
    Akush Ginekol (Mosk); 1990 Dec; (12):57-8. PubMed ID: 2090002
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute pelvic inflammatory disease.
    Eschenbach DA
    Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The etiology of pelvic inflammatory disease.
    Keith L; Berger GS
    Res Front Fertil Regul; 1984 May; 3(1):1-16. PubMed ID: 12179634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of CA125 levels in predicting laparoscopically confirmed salpingitis in patients with clinically diagnosed pelvic inflammatory disease.
    Moore E; Soper DE
    Infect Dis Obstet Gynecol; 1998; 6(4):182-5. PubMed ID: 9812251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CA 125 in acute pelvic inflammatory disease.
    Irvine LM; Shaw RW
    Br J Obstet Gynaecol; 1989 Oct; 96(10):1249-50. PubMed ID: 2590669
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute pelvic inflammatory disease: associations of clinical and laboratory findings with laparoscopic findings.
    Eschenbach DA; Wölner-Hanssen P; Hawes SE; Pavletic A; Paavonen J; Holmes KK
    Obstet Gynecol; 1997 Feb; 89(2):184-92. PubMed ID: 9015018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use.
    Buchan H; Villard-Mackintosh L; Vessey M; Yeates D; McPherson K
    Br J Obstet Gynaecol; 1990 Sep; 97(9):780-8. PubMed ID: 2242362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic actinomycosis and usage of intrauterine contraceptive devices.
    Kelly J; Aaron J
    Yale J Biol Med; 1982; 55(5-6):453-61. PubMed ID: 7183022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residues of pelvic inflammatory disease in intrauterine device users: a result of the intrauterine device or Chlamydia trachomatis infection?
    Guderian AM; Trobough GE
    Am J Obstet Gynecol; 1986 Mar; 154(3):497-503. PubMed ID: 3513579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries.
    Weström L
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):880-92. PubMed ID: 7008604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy.
    Halila H; Stenman UH; Seppälä M
    Cancer; 1986 Apr; 57(7):1327-9. PubMed ID: 3456253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
    Larsson B; Rodau S; Patek E
    Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further observations, mainly serological, on a cohort of women with or without pelvic inflammatory disease.
    Taylor-Robinson D; Stacey CM; Jensen JS; Thomas BJ; Munday PE
    Int J STD AIDS; 2009 Oct; 20(10):712-8. PubMed ID: 19759049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.